Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide

Radiation Research

Volumn 177, Issue 2, 2012, Pages 187-199

  Laiakis, Evagelia C ^a   Hyduke, Daniel R ^b   Fornace, Albert J ^a,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CARNITINE; CYTOSINE; HYDROCORTISONE; ISETHIONIC ACID; LIPOPOLYSACCHARIDE; O PROPANOYLCARNITINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXCRETION; GAMMA RADIATION; INFLAMMATION; IONIZING RADIATION; MALE; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SENSITIVITY AND SPECIFICITY; SEPSIS; TANDEM MASS SPECTROMETRY; URINE;

MUS;

EID: 84856455614     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2771.1     Document Type: Article

References (71)

1. Maguire H, Fraser G, Croft J, Bailey M, Tattersall P, Morrey M, et al. Assessing public health risk in the London polonium-210 incident, 2006. Public Health 2010; 124:313-8.
2. McFee RB, Leikin JB. Death by polonium-210: lessons learned from the murder of former Soviet spy Alexander Litvinenko. Semin Diagn Pathol 2009; 26:61-7.
3. Anjos RM, Umisedo NK, Facure A, Yoshimura EM, Gomes PR, Okuno E. Goiania: 12 years after the 137Cs radiological accident. Radiat Prot Dosimetry 2002; 101:201-4.
4. The radiological accident in Goiania. Vienna: International Atomic Energy Agency; 1988
5. DiCarlo AL, Ramakrishnan N, Hatchett RJ. Radiation combined injury: overview of NIAID research. Health Phys 2010; 98:863-7.
6. Donnelly EH, Nemhauser JB, Smith JM, Kazzi ZN, Farfan EB, Chang AS, et al. Acute radiation syndrome: assessment and management. South Med J 2010; 103:541-6.
7. Kuniak M, Azizova T, Day R, Wald N, Suyama J, Zhang A, et al. The Radiation Injury Severity Classification system: an early injury assessment tool for the frontline health-care provider. Br J Radiol 2008; 81:232-43. (Pubitemid 351547882)
8. Duranton C, Rubera I, L'hoste S, Cougnon M, Poujeol P, Barhanin J, et al. KCNQ1 K + channels are involved in lipopolysaccharideinduced apoptosis of distal kidney cells. Cell Physiol Biochem 2010; 25:367-78.
9. Liang YC, Liu HJ, Chen SH, Chen CC, Chou LS, Tsai LH. Effect of lipopolysaccharide on diarrhea and gastrointestinal transit in mice: roles of nitric oxide and prostaglandin E2. World J Gastroenterol 2005; 11:357-61. (Pubitemid 40125239)
10. Mathan VI, Penny GR, Mathan MM, Rowley D. Bacterial lipopolysaccharide- induced intestinal microvascular lesions leading to acute diarrhea. J Clin Invest 1988; 82:1714-21. (Pubitemid 19007778)
11. Opal SM. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 2007; 297:365-77. (Pubitemid 47188050)
12. Bahador M, Cross AS. From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J Endotoxin Res 2007; 13:251-79. (Pubitemid 350056223)
13. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007; 81:137-43. (Pubitemid 46021262)
14. Patterson AD, Lanz C, Gonzalez FJ, Idle JR. The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev 2010; 29:503-21.
15. Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, Luecke H, et al. Radiation metabolomics. 4. UPLC-ESIQTOFMS-based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res 2011; 175:473-84.
16. Lanz C, Patterson AD, Slavik J, Krausz KW, Ledermann M, Gonzalez FJ, et al. Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm. Radiat Res 2009; 172:198-212.
17. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJ Jr, Gonzalez FJ, et al. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res 2008; 170:1-14. (Pubitemid 351931182)
18. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJ Jr, Gonzalez FJ, et al. Radiation metabolomics. 2. Dose-and timedependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res 2009; 172:42-57.
19. Laiakis EC, Morris GA, Fornace AJ, Howie SR. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One 2010; 5:12655.
20. Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Humpfer E, Spraul M, et al. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 2010; 9:319-32.
21. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009; 457:910-4.
22. Calvani R, Capuani G, Tomassini Miccheli A, Puccetti C, Delfini M, et al. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 2010; 34:1095-8.
23. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106:3698-703.
24. Li HH, Aubrecht J, Fornace AJ Jr. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals. Mutat Res 2007; 623:98-108. (Pubitemid 47368576)
25. McCurley MC, Miller CW, Tucker FE, Guinn A, Donnelly E, Ansari A, et al. Educating medical staff about responding to a radiological or nuclear emergency. Health Phys 2009; 96 Suppl 2:S50-4.
26. Wilkinson D. Dealing with at-risk populations in radiological/nuclear emergencies. Radiat Prot Dosimetry 2009; 134:136-42.
27. Breiman L. Random forests. Machine Learning 2001; 45:5-32. (Pubitemid 32933532)
28. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 2004; 140:1037-51.
29. Laiakis EC, Baulch JE, Morgan WF. Cytokine and chemokine responses after exposure to ionizing radiation: implications for the astronauts. Adv Space Res 2007; 39:1019-25. (Pubitemid 46823937)
30. McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, et al. A sense of danger from radiation. Radiat Res 2004; 162:1-19. (Pubitemid 39044714)
31. Zhou H, Ivanov VN, Gillespie J, Geard CR, Amundson SA, Brenner DJ, et al. Mechanism of radiation-induced bystander effect: role of the cyclooxygenase-2 signaling pathway. Proc Natl Acad Sci USA 2005; 102:14641-6. (Pubitemid 41457109)
32. McAdam BF, Mardini IA, Habib A, Burke A, Lawson JA, Kapoor S, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest 2000; 105:1473-82. (Pubitemid 30322413)
33. Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 2009; 16:130-43.
34. Naderi EH, Findley HW, Ruud E, Blomhoff HK, Naderi S. Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood 2009; 114:608-18.
35. Csako G, Elin RJ, Hochstein HD, Tsai CM. Physical and biological properties of U.S. standard endotoxin EC after exposure to ionizing radiation. Infect Immun 1983; 41:190-6. (Pubitemid 13063038)
36. Gridley DS, Miller GM, Pecaut MJ. Radiation and primary response to lipopolysaccharide: bone marrow-derived cells and susceptible organs. In Vivo 2007; 21:453-61.
37. Jurecka A. Inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis 2009; 32:247-63.
38. Vuaden FC, de Paula Cognato G, Bonorino C, Bogo MR, de Freitas Sarkis JJ, Bonan CD. Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats. Life Sci 2007; 80:1784-91. (Pubitemid 46553703)
39. Heller AR, Rothermel J, Weigand MA, Plaschke K, Schmeck J, Wendel M, et al. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung. Eur J Anaesthesiol 2007; 24:258-66.
40. Saebo J, Ueland PM. A study on the sequestration of adenosine and its conversion to adenine by the cyclic AMP-adenosine binding protein/S- adenosylhomocysteinase from mouse liver. Biochim Biophys Acta 1979; 587:333-40. (Pubitemid 10192531)
41. Nyhan WL. Disorders of purine and pyrimidine metabolism. Mol Genet Metab 2005; 86:25-33. (Pubitemid 41417680)
42. Bollee G, Dollinger C, Boutaud L, Guillemot D, Bensman A, Harambat J, et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 2010; 21:679-88.
43. Micheli V, Massarino F, Jacomelli G, Bartelli M, Corradi MR, Guerrini A, et al. Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation. Nephrol Dial Transplant 2010; 3:436-8.
44. Mills GC, Schmalstieg FC, Newkirk KE, Goldblum RM. Cytosine and orotic acid in urine of immunodeficient children. Clin Chem 1979; 25:419-24. (Pubitemid 9142868)
45. Mills GC, Schmalstieg FC, Koolkin RJ, Goldblum RM. Urinary excretion of purines, purine nucleosides, and pseudouridine in immunodeficient children. Biochem Med 1982; 27:37-45. (Pubitemid 12170371)
46. Kang SM, Park JC, Shin MJ, Lee H, Oh J, Ryu DH, et al. 1H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin Biochem 2011; 44:293-9.
47. Wondergem R, Graves BM, Ozment-Skelton TR, Li C, Williams DL. Lipopolysaccharides directly decrease Ca2 + oscillations and the hyperpolarization-activated nonselective cation current If in immortalized HL-1 cardiomyocytes. Am J Physiol Cell Physiol 2010; 299:C665-71.
48. Simoni RE, Gomes LN, Scalco FB, Oliveira CP, Aquino Neto FR, de Oliveira ML. Uric acid changes in urine and plasma: an effective tool in screening for purine inborn errors of metabolism and other pathological conditions. J Inherit Metab Dis 2007; 30:295-309. (Pubitemid 46881676)
49. Roszkowski K, Gackowski D, Rozalski R, Dziaman T, Siomek A, Guz J, et al. Small field radiotherapy of head and neck cancer patients is responsible for oxidatively damaged DNA/oxidative stress on the level of a whole organism. Int J Cancer 2008; 123:1964-7.
50. Il'yasova D, Spasojevic I, Wang F, Tolun AA, Base K, Young SP, et al. Urinary biomarkers of oxidative status in a clinical model of oxidative assault. Cancer Epidemiol Biomarkers Prev 2010; 19:1506-10.
51. Causse E, Pradelles A, Dirat B, Negre-Salvayre A, Salvayre R, Couderc F. Simultaneous determination of allantoin, hypoxan-thine, xanthine, and uric acid in serum/plasma by CE. Electrophoresis 2007; 28:381-7.
52. Hsu HY, Wen MH. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002; 277:22131-9.
53. Spitz DR, Azzam EI, Li JJ, Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 2004; 23:311-22. (Pubitemid 38881814)
54. Lang R, Wahl A, Skurk T, Yagar EF, Schmiech L, Eggers R, et al. Development of a hydrophilic liquid interaction chromatographyhigh-performance liquid chromatography-tandem mass spectrometry based stable isotope dilution analysis and pharmacokinetic studies on bioactive pyridines in human plasma and urine after coffee consumption. Anal Chem 2010; 82:1486-97.
55. Mullangi R, Srinivas NR. Niacin and its metabolites: role of LCMS/MS bioanalytical methods and update on clinical pharmacology. An overview. Biomed Chromatogr 2011; 25:218-37.
56. Lin H, Kwan AL, Dutcher SK. Synthesizing and salvaging NAD: lessons learned from Chlamydomonas reinhardtii. PLoS Genet 2010; 6:e1001105.
57. Billing AM, Fack F, Turner JD, Muller CP. Cortisol is a potent modulator of lipopolysaccharide-induced interferon signaling in macrophages. Innate Immun 2011; 17:302-20.
58. Oguri S, Motegi K, Iwakura Y, Endo Y. Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharideinduced hypoglycemia in mice. Clin Diagn Lab Immunol 2002; 9:1307-12. (Pubitemid 35283295)
59. Grigoleit JS, Oberbeck JR, Lichte P, Kobbe P, Wolf OT, Montag T, et al. Lipopolysaccharide-induced experimental immune activation does not impair memory functions in humans. Neurobiol Learn Mem 2010; 94:561-7.
60. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58:445-52. (Pubitemid 32411324)
61. Zhang X, Tenner TEJ, Lombardini JB. Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues. Biochem Pharmacol 1999; 57:1331-9. (Pubitemid 29185155)
62. Sturman JA, Hepner GW, Hofmann AF, Thomas PJ. Metabolism of [35S]taurine in man. J Nutr 1975; 105:1206-14.
63. Huxtable R, Bressler R. Taurine and isethionic acid: distribution and interconversion in the rat. J Nutr 1972; 102:805-14.
64. Styp von Rekowski K, Denger K, Cook AM. Isethionate as a product from taurine during nitrogen-limited growth of Klebsiella oxytoca TauN1. Arch Microbiol 2005; 183:325-30. (Pubitemid 41158250)
65. Wikoff WR, Gangoiti JA, Barshop BA, Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007; 53:2169-76. (Pubitemid 350197301)
66. Ogier de Baulny H, Saudubray JM. Branched-chain organic acidurias. Semin Neonatol 2002; 7:65-74. (Pubitemid 34742220)
67. Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 2006; 142C:104-12.
68. Duran M, Ketting D, Beckeringh TE, Leupold D, Wadman SK. Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation. J Inherit Metab Dis 1986; 9:202-7. (Pubitemid 16092697)
69. Lucke T, Perez-Cerda C, Baumgartner M, Fowler B, Sander S, Sasse M, et al. Propionic acidemia: unusual course with late onset and fatal outcome. Metabolism 2004; 53:809-10. (Pubitemid 38880916)
70. Hulsmann WC. Biochemical profile of propionyl-l-carnitine. Cardiovasc Drugs Ther 1991; 5 Suppl 1:7-9.
71. Siliprandi N, Di Lisa F, Menabo R. Propionyl-l-carnitine: biochemical significance and possible role in cardiac metabolism. Cardiovasc Drugs Ther 1991; 5 Suppl 1:11-5.